Research Article
Molecular Detection of EMT Markers in Circulating Tumor Cells from Metastatic Non-Small Cell Lung Cancer Patients: Potential Role in Clinical Practice
Table 2
Clinical and histopathological characteristics of ten non-small cell lung cancer patients.
| Factors | Subgroup | N | % |
| Median age at baseline | | 69.9 y (45–70) | |
| Sex | Male | 6 | 60 | Female | 4 | 40 |
| Smoker | Yes | 5 | 50 | No | 2 | 20 | Unknown | 3 | 30 |
| ECOG PS | 0-1 | 10 | 100 | 2 | 0 | 0 |
| Histopathology | Adenocarcinoma | 9 | 90 | Squamous cell | 1 | 10 |
| Mutational status | EGFR mutation | 0 | 0 | ALK translocation | 1 | 10 | ROS1 translocation | 1 | 10 | None | 8 | 80 |
| Metastasis location | Bone | 1 | 10 | Liver | 1 | 10 | Contralateral lung | 4 | 40 | Adrenal gland | 1 | 10 | Brain | 3 | 30 |
| Chemotherapy | CDDP-pemetrexed | 7 | 70 | CDDP-gemcitabine | 2 | 20 | CDDP-taxotere | 1 | 10 |
|
|